Dr. Reddy’s Q3 & 9M FY21 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Dr. Reddys Labs (RDY) Reports Q3 EPS of $0.02
January 29, 2021 5:49 AM ESTDr. Reddys Labs (NYSE: RDY) reported Q3 EPS of $0.02, versus ($0.47) reported last year. Revenue for the quarter came in at $675 million, versus $600 million reported last year.
Commenting on the results, Co-chairman & MD, G V Prasad said, We continued with our growth momentum while... More
